Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rectal Neoplasms × Focus Groups × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Neoplasms 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Smoking Cessation 2 Prostatic Neoplasms 2 Communication 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1 Patient Preference 1 Patient Acceptance of Health Care 1 Papillary Thyroid Microcarcinoma 1 Melanoma 1 Hematologic Neoplasms 1 Health Behavior 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Cancer Prevention 1 Cancer Pain 1 Brain Neoplasms 1 Attitude to Health 1

Interventions

Fluorouracil 142 Oxaliplatin 121 Leucovorin 115 Capecitabine 82 Irinotecan 79 Radiotherapy 58 Bevacizumab 54 Cetuximab 33 Folfox protocol 24 Panitumumab 20 Neoadjuvant Therapy 20 Surgical Procedures, Operative 17 Chemotherapy, Adjuvant 15 Radiation 13 Floxuridine 13 Erlotinib Hydrochloride 12 Early Intervention, Educational 11 Proctectomy 10 IFL protocol 10 Drug Therapy 10 Counseling 10 Psychiatric Rehabilitation 8 Magnetic Resonance Spectroscopy 8 Surveys and Questionnaires 7 Immunohistochemistry 7 Celecoxib 7 aflibercept 6 Sorafenib 6 Radiotherapy, Intensity-Modulated 6 Methods 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551471 2018-08-09

PELVICARE

University Hospital, Bordeaux

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡